Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis

View source ↗

Summary

A Balikesir University-sponsored clinical trial is evaluating the relationship between anticholinergic burden and osteoporosis/fracture risk in people with rheu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Balikesir University | Conditions: Rheumatoid Arthritis (RA), Anticholinergic Adverse Reaction | Status: RECRUITING